Welcome to the future of personal diagnostics.
Welcome to the future of personal diagnostics.

Illustrative prototype – Copyright: Digital Diagnostics AG

Illustrative prototype – Copyright: Digital Diagnostics AG


digid is developing a breakthrough digital diagnostics platform built upon its proprietary nanotech CantisenseTM biosensor technology and an ecosystem of mobile applications to enable real-time, A.I-powered diagnostics of human and animal biodata.

Mission
Our mission is to bring the power of a laboratory to everyone’s smartphone.


digid is developing a breakthrough digital diagnostics platform built upon its proprietary nanotech CantisenseTM biosensor technology and an ecosystem of mobile applications to enable real-time, A.I-powered diagnostics of human and animal biodata.

Mission
Our mission is to bring the power of a laboratory to everyone’s smartphone.

Product
digid Cantisense™ SARS-CoV-2-Test
The “digid Cantisense™ SARS-Cov-2 Test“ is a novel point-of-care test kit for professional usage, allowing to determine within minutes whether a person is infected with the SARS-CoV-2 virus.

Illustrative prototype – Copyright: Digital Diagnostics AG

Product
digid Cantisense™ SARS-CoV-2-Test
The “digid Cantisense™ SARS-Cov-2 Test“ is a novel point-of-care test kit for professional usage, allowing to determine within minutes whether a person is infected with the SARS-CoV-2 virus.

Illustrative prototype – Copyright: Digital Diagnostics AG










Leveraging digid´s groundbreaking technology to fight Covid-19.


Leveraging digid´s groundbreaking technology to fight Covid-19.
The aim is to enable faster and more precise detection of the SARS-CoV-2 virus.

.01

.02


.01

.02


Technology
Applying innovative technologies to digitalize diagnostics from the ground up.

.01
digid is developing a new kind of diagnostics platform by combining our proprietary nanotech CantisenseTM biosensor technology and an ecosystem of mobile applications to enable real-time A.I-powered diagnostics of human and animal biodata.

.02

.03
Our real-time diagnostics solution enables the identification of human and animal biomarkers in real-time.


Technology
Applying innovative technologies to digitalize diagnostics from the ground up.

.01
digid is developing a new kind of diagnostics platform by combining our proprietary nanotech CantisenseTM biosensor technology and an ecosystem of mobile applications to enable real-time A.I-powered diagnostics of human and animal biodata.

.02

.03
Our real-time diagnostics solution enables the identification of human and animal biomarkers in real-time.


Team

Constantin von Gersdorff
CEO

Dr. Frank Flacke
COO

Dr. Konstantin Kloppstech
CTO

Press
After scientific breakthrough: Digid seeks FDA approval for its rapid corona antigen test
At the Helmholtz Centre for Infection Research (HZI), scientists have succeeded for the first time in detecting SARS-CoV-2 viruses using the revolutionary Cantisense™ technology from Digital Diagnostics AG. Application for approval of the Digid Cantisense™ SARS-CoV-2...
New 5 minute corona virus test delivers clear results on infection
A consortium of scientists and companies is developing a new 5 minute test for the SARS corona virus. In comparison to currently available rapid tests, the SARS-CoV-2 MEMS 5 Minute Test™ directly detects the virus over the entire course of the infection and can be...

Contact
Robert-Koch-Straße 30A
55129 Mainz
E-mail: info@digid.com
Press Inquiry
E: press@digid.com
T: +49 30 27580 81 11
©2020 Digital Diagnostics AG
Impressum // Data Policy // Disclamer